S R Group

CTLC (Cefotaxime + Clavulanic acid + Cloxacillin) refers to a specific type of antibiotic disk or strip used in Antimicrobial Susceptibility Testing (AST), particularly for detecting Extended-Spectrum Beta-Lactamase (ESBL)-producing bacteria, with Cloxacillin added to help identify certain Gram-positive resistant strains like MRSA, providing a comprehensive profile against various beta-lactamase threats in a single test. It's a specialized diagnostic tool, not a standard clinical treatment, helping labs determine which antibiotics will work against tricky infections, combining a cephalosporin (Cefotaxime) with beta-lactamase inhibitors (Clavulanic acid) and a penicillinase-resistant penicillin (Cloxacillin).